Company News Hub
Formation Bio News
No direct newsroom story is tagged to Formation Bio yet. Use this page with the linked company profile and hub routes to keep the chronology tied to the broader market context.
Coverage Snapshot: Formation Bio
Formation Bio is currently mapped as a Healthcare company at the Series C stage, with operating context centered on New York, New York, USA. The company summary on this route is: Automate and streamline the clinical trial process: 1.9X faster enrollment and 50% faster drug development timeline Healthcare Clinical Trials
What's Already Mapped
- Funding context: $156.00M, latest mapped round Series C (Sequoia, $156M Series C in 2021, $1.0B valuation).
- Founder coverage: Formation Bio Team
- Market lens: Healthcare | Series C | New York, New York, USA.
- Hiring watch: active role clusters include Open Roles.
Connected Routes
Related topics
Use the story feed below for chronology, then bounce back to the company profile and hub pages when you need peer, geography, or stage-level comparison.
No direct newsroom stories yet
We have not mapped a direct tagged article to Formation Bio yet. In practice, that usually means the coverage is currently showing up inside broader healthcare or market-wide stories rather than on a single company-specific route.
- Start with the company profile for the cleanest summary of current company data.
- Check United States newsroom for geography-specific momentum.
- Compare peers through Healthcare startup pages and Series C funding coverage.